- Thursday, May 4, 2023
8:00 AM – 8:15 AM CT
Welcome
8:00 AM – 8:15 AM CT
WelcomeCo-Chair: – University of California, Los Angeles
Co-Chair: – Abramson Cancer Center, Hospital of the University of Pennsylvania
Edward B. Garon, MD, MS – University of California, Los Angeles ### 758743###Co-Chair###Professor###University of California, Los Angeles###Co-Chair: – University of California, Los Angeles
### @@@ Corey J. Langer, MD, FACP (he/him/his) – Abramson Cancer Center, Hospital of the University of Pennsylvania ### 758413###Co-Chair###Director of Thoracic Oncology ###Abramson Cancer Center, Hospital of the University of Pennsylvania###Co-Chair: – Abramson Cancer Center, Hospital of the University of Pennsylvania
### he/him/his8:15 AM – 9:00 AM CT
Session 1: NSCLC: First-Line, Second-Line, Third-Line Treatment
8:15 AM – 9:00 AM CT
Session 1: NSCLC: First-Line, Second-Line, Third-Line TreatmentPresenter: – Cedars Sinai Medical Center
Karen Reckamp, MD – Cedars Sinai Medical Center ### 799344###Presenter###Professor###Cedars Sinai Medical Center###Presenter: – Cedars Sinai Medical Center
### 9:00 AM – 9:45 AM CT
Session 2: Special Topic –EGFR Mutation
9:00 AM – 9:45 AM CT
Session 2: Upfront Treatment in Sensitizing EGFR MutationPresenter: – Stanford University
Heather Wakelee, MD – Stanford University ### 1047211###Presenter###Professor of Medicine and Interim Chief of Oncology###Stanford University###Presenter: – Stanford University
### 9:45 AM – 10:45 AM CT
Non-CME Innovation Theater
9:45 AM – 10:45 AM CT
Non-CME Innovation Theater (Sponsored by AstraZeneca)
10:45 AM – 11:00 AM CT
Exhibit Hall
10:45 AM – 11:00 AM CT
Exhibit Hall
11:00 AM – 11:45 AM CT
Session 3: Special Topic – EGFR Mutation
11:00 AM – 11:45 AM CT
Session 3: Special Topic – EGFR Mutation Part II
11:45 AM – 12:30 PM CT
Session 4: Targeting ALK and ROS1: A Fusion Paradigm
11:45 AM – 12:30 PM CT
Session 4: Targeting ALK and ROS1: A Fusion ParadigmPresenter: – Northwestern University
Jyoti Patel, MD – Northwestern University ### 1931710###Presenter###Professor###Northwestern University###Presenter: – Northwestern University
### 12:30 PM – 1:30 PM CT
Non-CME Innovation Theater
12:30 PM – 1:30 PM CT
Non-CME Innovation Theater (Sponsored by Sanofi)
1:30 PM – 2:15 PM CT
Session 5: Special Topic – Fusions as a Target in Lung Cancer Part II
1:30 PM – 2:15 PM CT
Session 5: Special Topic – Fusions as a Target in Lung Cancer Part II
2:15 PM – 3:00 PM CT
Session 6: Special Topic – Fusions as a Target in Lung Cancer Part III
2:15 PM – 3:00 PM CT
Session 6: Special Topic – Fusions as a Target in Lung Cancer Part III
3:00 PM – 3:30 PM CT
Exhibit Hall
3:00 PM – 3:30 PM CT
Exhibit Hall
3:30 PM – 4:15 PM CT
Session 7: Special Topic – Targeted Therapy for Lung Cancers Part I
3:30 PM – 4:15 PM CT
Session 7: Special Topic – Targeted Therapy for Lung Cancers Part I
4:15 PM – 5:00 PM CT
Session 8: Targeted Therapy for MET-Dependent Lung Cancers: Have We Met Our Match?
4:15 PM – 5:00 PM CT
Session 8: Targeted Therapy for MET-Dependent Lung Cancers: Have We Met Our Match?
David Spigel ### 1612024###Invited Speaker#########Invited Speaker:
###
